We might have thought the COVID-19 pandemic would be over by year-end 2021, but experts now say—and the omicron variant suggests—the virus will likely always be with us. What pandemic lessons has the industry learned that can help tackle longtime challenges—such as speeding up drug development, adding new diversity into clinical trials, launching new products and, of course, identifying the next cutting edge in science?   At Fierce JPM Week we're bringing together our community to focus on these…